Digestive System Neoplasm Clinical Trials in Shanghai, Shanghai Municipality
2 recruitingShanghai, Shanghai Municipality, China
Showing 1–2 of 2 trials
Recruiting
Not Applicable
Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study
Carcinoma, HepatocellularLiver NeoplasmsAdenocarcinoma+2 more
Shanghai Zhongshan Hospital17 enrolled1 locationNCT06794073
Recruiting
Not Applicable
Target-specific immunoPET Imaging of Digestive System Carcinoma
MalignancyLiver CancerPancreatic Cancer+12 more
RenJi Hospital400 enrolled1 locationNCT06715839